ArticleVaccines2022

Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022.

Jeadran Malagón-Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.